期刊文献+

78例小细胞肺癌患者脑转移发生时间的相关因素初步研究 被引量:5

Preliminary study on the relative factors of the time for brain metastasis in 78 small cell lung cancer
原文传递
导出
摘要 目的:对小细胞肺癌患者发生脑转移时间的影响因素进行分析。方法:统计78例发生脑转移的小细胞肺癌患者的临床资料,采用住院观察和电话形式进行随访,应用卡方检验进行单因素分析,行Logistic多因素分析,得出独立危险因素。结果:单因素分析显示,患者发生脑转移的时间与确诊时分期(χ~2=7.657,P=0.006)、确诊时血清NSE水平(χ~2=5.200,P=0.023)、是否行预防性全脑照射(PCI)治疗(χ~2=5.200,P=0.023)和是否行手术切除治疗(χ~2=3.989,P=0.046)有关。多因素分析显示,广泛期和未行PCI治疗是小细胞肺癌较早发生脑转移的独立危险因素。结论:广泛期和未行PCI治疗的小细胞肺癌患者更易较早发生脑转移,采用PCI治疗后可延迟发生脑转移的时间。对小细胞肺癌患者病灶及症状得到控制后,应尽早行PCI治疗。 Objective:To evaluate influencing factors on the time that patients ocurre brain metastasis in small cell lung cancer.Methods:Clinical data of 78 patients with brain metastasis in small cell lung cancer were collected,followed up by telephone interview and hospitalization observation.Using Chi-square univariate analysis was conducted to obtain the independent risk factors by the multivariate logistic analysis.Results:Single factor analysis showed that the time of brain metastasis in small cell lung cancer patients was related with diagnosis staging(χ^2=7.657,P=0.006),the level of serum NSE in diagnosis(χ^2=5.200,P=0.023),PCI treatment(χ^2=5.200,P=0.023) and surgery(χ^2=3.989,P=0.046).The multivariate analysis concluded that ED-SCLC and without PCI were the independent risk factors for early brain metastasis in small cell lung cancer.Conclusion:The patients who were ED-SCLC or treated without PCI were more likely to occur early brain metastasis.However,patients treated with PCI can delay the time of brain metastasis.When patients are in stable situation,we should reco mmend tailored PCI as soon as possible
作者 管超 黄鲁众 于莉 崔国元 徐兆国 张晓晔 GUAN Chao;HUANG Lu- zhong;YU Li;CUI Guo- yuan;XU Zhao- guo;ZHANG Xiao- ye(The Fourth Oncology Department, Shengfing Hospital of China Medical University, Shenyang 110020, China)
出处 《现代医学》 2017年第11期1642-1645,共4页 Modern Medical Journal
关键词 小细胞肺癌 脑转移 预防性全脑照射 危险因素 small cell lung cancer brain metastasis prophylactic cranial irradiation risk factor
  • 相关文献

参考文献2

二级参考文献11

  • 1Saijo N.Progress in treatment of small-cell lung cancer:role of CPT-11[J].British Journal of Cancer,2003,89 (12):2178-2183.
  • 2Spira A,Ettinger DS.Multidisciplinary management of lung cancer[J].N Engl J Med,2004,350:379-392.
  • 3Hansen HH,Pappot H.Primary malignant tumors of the lung and pleura[M] //Cavalli F,Hansen HH,Kaye SB.Textbook of Medical Oncology.London:Martin Dunitz,1997:139-157.
  • 4Chute JP,Venzon DJ,Hankins L,et al.Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute[J].Mayo Clin Proc,1997,72:901-912.
  • 5Quoix E,Purohit A,Faller-beau M,et al.Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy[J].Lung Cancer,2000,30:127-134.
  • 6Shibayama T,Ueoka K,Nishii K,et al.Complementary roles of pro-gastrin-releasing peptide(ProGRP) and neuron specific enolase(NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC)[J].Lung Cancer,2001,32:61-69.
  • 7Pujol JL,Quantin X,Jacot W,et al.Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer[J].Lung Cancer,2003,39:131-138.
  • 8Bonner JA,Sloan JA,Rowland KM Jr,et al.Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer[J].Clinical Cancer Res,2000,6 (2):597-601.
  • 9Chrystal K,Cheong K,Harper P.Chemotherapy of small cell lung cancer:state of the art[J].Curr Opin Oncol,2004,16(2):136-140.
  • 10施文,李俊生.ADAM家族与肿瘤关系的研究现状[J].实用癌症杂志,2008,23(6):671-673. 被引量:7

共引文献8

同被引文献36

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部